Clorox (NYSE:CLX – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 6.650-6.900 for the period, compared to the consensus EPS estimate of 6.650. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Clorox also updated its FY25 guidance to $6.65-$6.90 EPS.
Wall Street Analyst Weigh In
CLX has been the subject of a number of analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $150.29.
Get Our Latest Research Report on Clorox
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 292.08% and a net margin of 4.78%. The business’s revenue was up 27.0% on a year-over-year basis. During the same period last year, the business earned $0.49 earnings per share. As a group, equities research analysts anticipate that Clorox will post 6.64 earnings per share for the current year.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.
Insider Buying and Selling
In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.57% of the company’s stock.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- What Are the FAANG Stocks and Are They Good Investments?
- Battle of the Retailers: Who Comes Out on Top?
- 3 Tickers Leading a Meme Stock Revival
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What Are Dividend Contenders? Investing in Dividend Contenders
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.